+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cell membrane signaling as target in cancer therapy ii. inhibitory effect of n n n trimethylsphingosine on metastatic potential of murine b16 melanoma cell line through blocking of tumor cell dependent platelet aggregation



Cell membrane signaling as target in cancer therapy ii. inhibitory effect of n n n trimethylsphingosine on metastatic potential of murine b16 melanoma cell line through blocking of tumor cell dependent platelet aggregation



Cancer Research 51(22): 6019-6024



Two phenotypic parameters, aberrant expression of protein kinase C and tumor cell-induced platelet aggregation (PA), have been correlated with abnormal growth behavior and metastatic potential of tumor cells. We recently observed that N,N,N-trimethylsphingosine (TMS) and N,N-dimethylsphingosine (DMS), but not sphingosine (SPN), had an inhibitory effect (via blocking of transmembrane signaling) on the growth of various human tumor cell lines in vitro as well as in vivo in nu/nu mice (K. Endo et al., Cancer Res., 51: 1613-1618, 1991). We therefore investigated the effects of TMS, DMS, and SPN on (a) PA induced by ADP and thrombin; (b) PA induced by melanoma cell line B16/BL6; and (c) experimental lung colonization as well as spontaneous lung metastasis of BL6 cells in syngeneic C57BL/6 mice. In experiments on agonist-induced PA, TMS inhibited PA and ATP secretion 5-fold more strongly than DMS or SPN. This effect may be based on the inhibition of Mr 47,000 platelet protein phosphorylation and/or inhibition of phosphatidylinositol turnover as a transmembrane signaling pathway in platelets. Tumor cell (BL6 melanoma)-induced PA and ATP secretion were also strongly inhibited by TMS, but not by DMS or SPN. Unlike ADP- or thrombin-induced PA, BL6 cell-induced PA was not inhibited by Calphostin-C (a potent protein kinase C inhibitor) or cilostazol (a potent inhibitor of PA based on inhibition of cyclic AMP phosphodiesterase). Since many previous studies suggested that the ability of tumor cells to induce PA is related to the degree of malignancy (e.g., metastatic potential) of tumor cells, we studied the effect of TMS on lung metastatic potential. Three independent sets of experiments, as described below, all showed clear inhibition of lung metastasis by administration of TMS: (a) i.v. coinjection of BL6 melanoma cells and TMS; (b) i.v. injection of TMS and 1 h later, BL6 cells; (c) spontaneous metastasis to lung from s.c. BL6 tumor (TMS administration after establishment of tumor, followed by resection of tumor). In comparison to tumor growth inhibition produced by TMS or DMS, inhibition of melanoma metastasis by TMS is obvious at lower doses.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 007086154

Download citation: RISBibTeXText

PMID: 1657377


Related references

Inhibitory effect effect of n n n trimethylsphingosine tms on metastatic potential of murine b16 melanoma cell line through blocking of tumor cell dependent platelet aggregation. FASEB Journal 6(4): A1358, 1992

Cooperative inhibitory effect of N,N,N-trimethylsphingosine and sphingosine-1-phosphate, co-incorporated in liposomes, on B16 melanoma cell metastasis: Cell membrane signaling as a target in cancer therapy IV. International Journal of Oncology 7(3): 487-494, 1995

Liposomal N,N,N-trimethylsphingosine (TMS) as an inhibitor of B16 melanoma cell growth and metastasis with reduced toxicity and enhanced drug efficacy compared to free TMS: cell membrane signaling as a target in cancer therapy III. Cancer Research 54(8): 2213-2217, 1994

Characterization of platelet aggregation induced by the human melanoma cell line HMV-I: roles of heparin, plasma adhesive proteins, and tumor cell membrane proteins. Cancer Research 51(4): 1286-1293, 1991

Cell membrane signaling as target in cancer therapy: inhibitory effect of N,N-dimethyl and N,N,N-trimethyl sphingosine derivatives on in vitro and in vivo growth of human tumor cells in nude mice. Cancer Research 51(6): 1613-1618, 1991

Tumor-cell-platelet aggregation does not correlate with metastatic potential of rat 13762NF mammary adenocarcinoma tumor cell clones. International Journal of Cancer 34(1): 101-105, 1984

Establishment of a human lung squamous cell carcinoma cell line LK-17, and characterization of procoagulant, platelet aggregation and metastatic potential. Human Cell 6(3): 226-230, 1993

Role of tumor cytoskeleton and membrane glycoprotein IRGpIIb/IIIa in platelet adhesion to tumor cell membrane and tumor cell-induced platelet aggregation. Cancer Research 48(13): 3787-3800, 1988

Characterisation of platelet aggregation induced by the human carcinosarcoma colo 526 Role of platelet activation, tumor cell cytoskeleton and tumor cell plasma membrane. Fibrinolysis 10(Suppl. 3): 44, 1996

Characterization of platelet aggregation induced by the human carcinosarcoma Colo 526: role of platelet activation, tumor cell cytoskeleton and tumor cell plasma membrane. Pathology 29(2): 189-195, 1997

Metastatic potential correlates with cell surface platelet aggregation potential and cell surface sialic acid of 10 variant pw 20 wistar furth renal sarcoma cell lines. Clinical Research 28(2): 420A, 1980

Correlation between spontaneous metastatic potential platelet aggregating activity of cell surface extracts and cell surface sialylation in 10 metastatic variant derivatives of a rat renal sarcoma cell line. Proceedings of the National Academy of Sciences of the United States of America 77(7): 4336-4339, 1980

Cancer stemness and metastatic potential of the novel tumor cell line K3: an inner mutated cell of bone marrow-derived mesenchymal stem cells. Oncotarget 8(24): 39522-39533, 2017

Molecular mechanisms of cancer cell-cell interactions: cell-cell adhesion-dependent signaling in the tumor microenvironment. Cell Adhesion and Migration 6(4): 344-345, 2013

Generation of t cell growth factor dependent splenic lymphoid cell line with cell mediated immunosuppressive reactivity against syngeneic murine tumor. European Journal of Cancer & Clinical Oncology 21(2): 257-262, 1985